NITRAZEPAM — all Canadian products
10 DINs
2 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is NITRAZEPAM, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 00511536 | MOGADON | AA PHARMA INC | Tablet | Oral | NITRAZEPAM 10 MG | Marketed | |
| 00511528 | MOGADON | AA PHARMA INC | Tablet | Oral | NITRAZEPAM 5 MG | Marketed | |
| 02245230 | APO-NITRAZEPAM | APOTEX INC | Tablet | Oral | NITRAZEPAM 5 MG | Dormant | |
| 02245231 | APO-NITRAZEPAM | APOTEX INC | Tablet | Oral | NITRAZEPAM 10 MG | Dormant | |
| 02229654 | NITRAZADON | AA PHARMA INC | Tablet | Oral | NITRAZEPAM 5 MG | Cancelled Post Market | |
| 02229655 | NITRAZADON | AA PHARMA INC | Tablet | Oral | NITRAZEPAM 10 MG | Cancelled Post Market | |
| 02255588 | NITRAZEPAM-10 | PRO DOC LIMITEE | Tablet | Oral | NITRAZEPAM 10 MG | Cancelled Post Market | |
| 02255561 | NITRAZEPAM-5 | PRO DOC LIMITEE | Tablet | Oral | NITRAZEPAM 5 MG | Cancelled Post Market | |
| 02234007 | SANDOZ NITRAZEPAM | SANDOZ CANADA INCORPORATED | Tablet | Oral | NITRAZEPAM 10 MG | Cancelled Post Market | |
| 02234003 | SANDOZ NITRAZEPAM | SANDOZ CANADA INCORPORATED | Tablet | Oral | NITRAZEPAM 5 MG | Cancelled Post Market |
Browse other molecules: